S. Sami Karti* , Zekaver Odabasi†, Volkan Korten†, Mustafa Yilmaz*, Mehmet Sonmez*, Rahmet Caylan*, Elif Akdogan*, Necmi Eren*, Iftihar Koksal*, Ercument Ovali*, Bobbie R. Erickson‡, Martin J. Vincent‡, Stuart T. Nichol‡, James A. Comer‡, Pierre E. Rollin‡, and Thomas G. Ksiazek‡
Author affiliations: *Karadeniz Technical University, School of Medicine, Trabzon, Turkey; †Marmara University School of Medicine, Istanbul, Turkey; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Figure 2. Geographic distribution of patients with Crimean-Congo hemorrhagic fever (CCHF), Turkey, 2002–2003. Residency of the patients with CCHF infection from our series is marked in the circle. Epicenter of a concurrent outbreak presented at the recent conference in Ankara is shown as a rectangle.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.